US 7173112
Antibody to GALP and uses thereof
granted A61KA61K2039/505A61P
Quick answer
US patent 7173112 (Antibody to GALP and uses thereof) held by Takeda Pharmaceutical Company Limited expires Mon Feb 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Feb 06 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K2039/505, A61P, A61P13/08, A61P13/12